Rx · PZN 17397645, 17397697, 17397705, 18045807…
RINVOQ 30 mg prolonged-release tablets
German trade nameRINVOQ 30 mg Retardtabletten
Consistently available
9.6out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
RINVOQ 30 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.
Review purchasing termsRINVOQ 30 mg prolonged-release tablets contains the active ingredient Upadacitinib and comes as Prolonged-release tablets. 9 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 9.6 out of 10. The best-available pack was consistently available.
Pack sizes · 9 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 17397705 | 9.4 | 9.6 | ~ €3,792 |
| 17397645 | 9.3 | 9.4 | ~ €1,264 |
| 17397697 | 0.0 | 0.0 | N/A |
| 18045807 | 0.0 | 0.0 | ~ €1,118 |
| 18045813 | 0.0 | 0.0 | ~ €3,911 |
| 19909598 | 0.0 | 0.0 | ~ €1,118 |
| 20222524 | 0.0 | 0.0 | ~ €3,911 |
| 19971864 | 0.0 | 0.0 | ~ €1,118 |
| 19971870 | 0.0 | 0.0 | ~ €3,911 |
We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.
Get in touch